Roche Says MS Drug Ocrevus Launch Its 'Best So Far', Vows To Help US Reform
Executive Summary
Roche said MS drug Ocrevus should generate sales of CHF2bn in its first full year after launch. The Swiss group also pledged to actively help the Trump Administration with its healthcare reform program.